Peijia Medical Ltd
HKEX:9996
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Peijia Medical Ltd
Free Cash Flow
Peijia Medical Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Peijia Medical Ltd
HKEX:9996
|
Free Cash Flow
-¥285.3m
|
CAGR 3-Years
21%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Free Cash Flow
¥682.2m
|
CAGR 3-Years
45%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Free Cash Flow
¥1.3B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
13%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Free Cash Flow
¥8.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Free Cash Flow
-¥11.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Free Cash Flow
-¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Peijia Medical Ltd
Glance View
Peijia Medical Ltd. engages in the manufacture and sale of medical devices. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-05-15. Through its subsidiaries, the Company operates two segments. Transcatheter Valve Therapeutic Business segment is mainly engaged in the development of transcatheter valve therapeutic medical devices. Neurointerventional Business segment is engaged in the research and development of neurointerventional procedural medical devices. The firm's main products under development include TaurusOne, TaurusElite, TaurusNXT and others. The firm operates its businesses primarily in domestic market.
See Also
What is Peijia Medical Ltd's Free Cash Flow?
Free Cash Flow
-285.3m
CNY
Based on the financial report for Dec 31, 2025, Peijia Medical Ltd's Free Cash Flow amounts to -285.3m CNY.
What is Peijia Medical Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-6%
Over the last year, the Free Cash Flow growth was 0%. The average annual Free Cash Flow growth rates for Peijia Medical Ltd have been 21% over the past three years , -6% over the past five years .
